Better shared decision-making could help patients feel more empowered, avoid treatment side-effects and reduce overtreatment.

Cancer biologists and engineers collaborated on a device that could help predict the likelihood of breast cancer metastasis.

Michigan-led research presents a new way of uncovering predictive biomarkers when data from large randomized trials aren’t available.

A 600-patient randomized clinical trial supports pembrolizumab and chemotherapy as a first-line treatment

A new study finds that U-M-designed compounds led to significantly smaller, slower-growing tumors.

A new approach to RNA sequencing reveals thousands of previously inaccessible RNA fragments in blood plasma that might serve as disease- and organ-specific biomarkers.